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The city of Wuhan in China is the focus of global attention due to an outbreak of a febrile 
respiratory illness due to a novel coronavirus. In December 2019, there was an outbreak of 
pneumonia of unknown cause in Wuhan, Hubei province in China, with an epidemiological link 
to the Huanan Seafood Wholesale Market where there was also sale of live animals. Notification 
of the WHO on 31 Dec 2019 by the Chinese Health Authorities has prompted health authorities 
in Hong Kong, Macau, and Taiwan to step up border surveillance, and generated concern and 
fears that it could mark the emergence of a novel and serious threat to public health.1,2  
 
The Chinese health authorities have taken prompt public health measures including intensive 
surveillance, epidemiological investigations, and closure of the market on 1 Jan 2020. SARS-
CoV, MERS-CoV, avian influenza, influenza and other common respiratory viruses were ruled 
out. The Chinese scientists were able to isolate a novel CoV from a patient within a short time 
on 7 Jan 2020 and perform genome sequencing of the novel CoV. The genetic sequence of the 
novel CoV has become available to the WHO on 12 Jan 2020 and this has facilitated the 
laboratories in different countries to produce specific diagnostic PCR tests for detecting the 
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novel infection.3 The novel CoV is a β CoV of group 2B with at least 70% similarity in genetic 
sequence to SARS-CoV. 
 
SARS is a zoonosis caused by SARS-CoV, which first emerged in China in 2002 before spreading 
to 29 countries/regions in 2003 through a travel-related global outbreak with 8,098 cases with 
a case fatality rate of 9.6%.  Nosocomial transmission of SARS-CoV was common while the 
primary reservoir was bats and the intermediary source was civet cats in the wet markets in 
Guangdong.4 MERS is a novel lethal zoonotic disease of humans endemic to the Middle East, 
caused by MERS-CoV. Humans are thought to acquire MERS-CoV infection though contact with 
camels or camel products with a case fatality rate close to 35% while nosocomial transmission 
is also a hallmark.5 The recent outbreak of clusters of viral pneumonia due to a novel CoV in 
the Wuhan market poses significant threats to international health and may be related to sale 
of wild animal as game food at the seafood market. 
 
As of 10 Jan 2020, 41 patients have been diagnosed to have infection by the novel CoV. The 
onset of illness of the 41 cases ranges from 8 December 2019 to 2 January 2020. Symptoms 
include fever (>90% cases), malaise, dry cough (80%), shortness of breath (20%) and respiratory 
distress (15%). The vital signs were stable in most of the cases while leucopenia and 
lymphopenia were common. Among the 41 cases, six patients have been discharged, seven 
patients are in critical care and one died, while the remaining patients are in stable condition. 
The fatal case involved a 61 year-old man with an abdominal tumour and cirrhosis who was 
admitted to a hospital due to respiratory failure and severe pneumonia. The diagnoses included 
severe pneumonia, acute respiratory distress syndrome, septic shock and multi-organ failure. 
The novel CoV infection in Wuhan appears clinically milder than SARS or MERS overall in terms 
of severity, case fatality rate and transmissibility. There is currently no clear evidence of human 
to human transmission. At present, 739 close contacts including 419 healthcare workers are 
being quarantined and monitored for any development of symptoms.3,6 No new cases have been 
detected in Wahung since 3 January 2020. However the first case outside China has been 
reported today, 13th January 2020 in a Chinese tourist visiting Thailand, who is being treated in 
hospital. 
 
The Chinese Health Authorities have carried out very appropriate and prompt response 
measures including active case finding, and retrospective investigations of the current cluster 
of patients which have been completed; The Huanan Seafood Wholesale Market has been 
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temporarily closed to carry out investigation, environmental sanitation and disinfection; Public 
risk communication activities have been carried out to improve public awareness and adoption 
of self-protection measures. Technical guidance on novel coronavirus has been developed and 
will continue to be updated as additional information becomes available. 
 
However, many questions about the new coronavirus remain. While it appears to be transmitted 
to humans via animals, the specific animals and other reservoirs need to be identified, the 
transmission route, the incubation period and characteristics of the susceptible population and 
survival rates. At present, there is however very limited clinical information of the novel CoV 
infection and data are missing in regard to the age range, animal source of the virus, incubation 
period, epidemic curve, viral kinetics, transmission route, pathogenesis, autopsy findings and 
any treatment response to antivirals among the severe cases. Once there is any clue to the 
source of animals being responsible for this outbreak, global public health authorities should 
examine the trading route and source of movement of wild animals from other parts to Wuhan 
and prevent further such trade which is posing risk to human health. The rapid identification 
and containment of a novel coronavirus virus rapidly in a short period of time (phylogenetic 
tree Archive Number: 20200112.6885385) is a re-assuring and a commendable achievement by 
China’s public health authorities and reflects the increasing global capacity to detect, identify, 
define and contain new outbreaks. 
 
This outbreak brings back memories of of the novel coronavirus outbreak in China, the severe 
acute respiratory syndrome (SARS) in China in 2003, caused by a novel SARS-CoV-coronavirus.7 
SARS-CoV rapidly spread from southern China in 2003 and infected more than 3,000 people, 
killing 774 by 2004, and then disappeared - never to be seen again.  
However, The Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV)8, a lethal 
zoonotic pathogen that was first identified in humans in the Kingdom of Saudi Arabia (KSA) in 
2012 continues to show up through intermittent sporadic cases, community clusters and 
nosocomial outbreaks. Between 2012 and December 2019, a total of 2465 laboratory-confirmed 
cases of MERS-CoV infection, including 850 deaths (34.4% mortality) were reported from 27 
countries to WHO, the majority of which were reported by KSA (2073 cases, 772 deaths. Whilst 
several important aspects of MERS-CoV epidemiology, virology, mode of transmission, 
pathogenesis, diagnosis, clinical features, have been defined, there remain many unanswered 
questions, including source, transmission and epidemic potential.  The Wuhang outbreak is a 
stark reminder of the continuing threat of zoonotic diseases to global health security. More 
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funder and governmental investments are required for a more concerted and collaborative 
global effort, learning from experiences from all geographical regions, through a ‘ONE-HUMAN-
ENIVRONMENTAL-ANIMAL-HEALTH’ global consortium to reduce the global threat of zoonotic 
diseases.9  
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